Key risks of combining berberine and semaglutide include: Low blood sugar (hypoglycemia), particularly if you also use insulin or sulfonylureas Worsening GI symptoms such as nausea, cramping, bloating, diarrhea, or constipation Drug interactions from berberines effects on liver enzymes, which can change levels of other prescriptions These risks are the reason a clinician should review your full situation before you start the combo
People are now filing GLP-1 lawsuits over claims that they experienced vision loss after taking these drugs
The radiation protection regulations from the International Commission for Radiological Protection (ICRP) set the limit for occupational exposure to 20 mSv per year of effective dose, averaged over a defined period of 5 years (100 mSv in 5 year), with no yearly dose exceeding 50 mSv (200)
However, there are significant financial and physiological barriers to getting bariatric surgery, making it an out-of-reach option for many patients
Our guide on GLP-1 maintenance dosing explores this approach in detail
Weight loss results with tirzepatide can vary